Showing results (71-80 of 554) with videos related to
Sort By:
Pageof 56
Therapeutic Advances in Medical Oncology|July 25, 2014
Castration-resistant prostate cancer: latest evidence and therapeutic implicationsDaniel L Suzman, Emmanuel S AntonarakisAsian Journal of Andrology|August 27, 2014
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for allBenjamin L Maughan, Emmanuel S AntonarakisInternational Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2016
Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerationsAlan H Bryce, Emmanuel S AntonarakisTranslational Cancer Research|October 15, 2016
The STAMPEDE trial: paradigm-changing data through innovative trial designBradley C Carthon, Emmanuel S AntonarakisCurrent Treatment Options in Oncology|November 9, 2016
Sequencing Treatment for Castration-Resistant Prostate CancerCatherine E Handy, Emmanuel S AntonarakisClinical Medicine Insights. Oncology|July 31, 2012
Immunotherapy for prostate cancer enters its golden ageSosipatros A Boikos, Emmanuel S AntonarakisClinical Oral Investigations|June 4, 2020
Spontaneous eruption of impacted maxillary incisors after surgical extraction of supernumerary teeth: a systematic review and meta-analysisRaji Pescia, Stavros Kiliaridis, Gregory S AntonarakisNeuromuscular Disorders : NMD|February 1, 2020
Management of the dentoalveolar effects of tongue hypertrophy in patients with Duchenne muscular dystrophy: A pilot studyGregory S Antonarakis, Catherine Morel, Stavros KiliaridisThe Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|January 21, 2014
The need for orthognathic surgery in nonsyndromic patients with repaired isolated cleft palateGregory S Antonarakis, Guy Watts, John DaskalogiannakisHormones & Cancer|July 23, 2014
Androgen receptor splice variants in the era of enzalutamide and abirateroneMary Nakazawa, Emmanuel S Antonarakis, Jun LuoPageof 56